Developer docs
API playgroundTry for free, no card

Search company profiles

Synergy IB Investment

Full company profile

uuid000d921

Namestring
Synergy IB Investment
Legal namestring
Synergy IB Investment Co., Ltd.
Websiteurl
synergyib.co.kr
Company typeenum
Private
Founded yearint
2014
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersYongsan, South Korea
HQ citystring
Yongsan
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
private investment management, venture capital funding, growth capital investing, fund management services, capital markets advisory
Industry1 code
1Investment Management Advisory (RIA)
CodeFSAEAAABPrimaryYes
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • Other Investment Pools and Funds5259
SIC code1 code
  • Investment Advice6282
Product category
Private Equity & Venture Capital Investment Management
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Fund Management Fees and Carried Interest
TypeSubscription Recurring
Description

Synergy IB Investment generates revenue through managing investment funds, including management fees and performance-based carried interest from successful portfolio company exits. The firm has demonstrated strong exit performance with 107 fully exited investments.

synergyib.co.kr
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Synergy IB Investment is a Korean private investment firm that raises and manages multiple investment funds backed by top-tier domestic financial institutions, providing continuous capital supply and strategic value creation to growth-stage companies from startup through IPO and beyond. The firm deploys capital via direct equity investments, charging management fees and carried interest, and has accumulated KRW 1.1 trillion in AUM across 558 deals, 162 funds raised, and 107 fully exited investments with a 23.2% average gross IRR.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 23.2% average gross IRR achieved across portfolio
+2 more records
Product overview1 text field

Synergy IB Investment operates as a single, unified investment management platform offering full-lifecycle capital support to companies from startup through IPO and beyond. The firm manages investment funds across multiple stages and sectors, providing strategic capital allocation, deal structuring, and portfolio management services to its limited partners and portfolio companies. Founded in 2014, the firm has raised 162 funds with KRW 1.1 trillion in AUM across 558 deals, delivering a 23.2% average gross IRR through disciplined, cycle-resilient investing. The firm does not appear to offer distinct named investment products or sub-brands based on available information.

Product and service2 records
1Investment Fund Management
CategoryInvestment Fund Management
Description

Management of multiple investment funds backed by top-tier Korean financial institutions, with 162 funds raised and KRW 1.1 trillion in accumulated AUM across 558 deals. The service targets Korean growth-stage companies and institutional limited partners, delivering a 23.2% average gross IRR through cycle-resilient investing with a 2.5-year average holding period.

2Full-Cycle Equity Capital Deployment
CategoryPrivate Equity Investment
Description

Direct equity investment in Korean growth-stage companies across every stage of the corporate lifecycle, from startup through IPO and post-IPO expansion. Supported 200+ portfolio companies as evidenced, providing continuous capital supply and strategic value creation alongside funding.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

PE/VC arm of KB Financial Group, one of Korea's largest financial groups, managing multiple funds with institutional LPs across growth stages — directly comparable in scale, LP base, and Korean capital markets focus.

TypeDirect peer
Description

Korean PE/VC firm raising and managing multiple growth and venture funds backed by Korean financial institutions; directly comparable in fund vintage model and growth-stage deal sourcing.

TypeDirect peer
Description

Korean private equity firm managing growth and buyout funds with institutional LP backing; comparable to Synergy in fund structure, Korean institutional capital base, and full-lifecycle investment approach.

TypeDirect peer
Description

Korean private investment firm managing multiple funds focused on growth-stage companies with institutional LP backing; similar in structure, target segment, and domestic Korean market focus to Synergy IB.

TypeDirect peer
Description

One of Korea's largest and most established venture capital and growth equity firms, managing multi-stage funds with top-tier Korean institutional LPs — a direct comparator to Synergy IB's growth-stage investment model.

TypeDirect peer
Description

Investment arm of the Mirae Asset Financial Group, managing PE/VC funds and direct investments in Korean growth companies; comparable in institutional LP base and capital markets discipline.

TypeDirect peer
Description

Korean venture and growth capital firm managing multiple funds backed by Korean financial institutions, with a similar full-lifecycle investment thesis.

TypeDirect peer
Description

Korean private investment firm managing growth-stage funds with institutional LP backing, similar fund vintage structure and disciplined investment approach.

TypeDirect peer
Description

Korean early-stage investor that co-led the PhyxUp Health seed round with Synergy IB; operates a comparable fund-driven model investing in growth-stage and cross-border Korean-led deals.

TypeRegional player
Description

Early-stage Korean VC focused on Korean founders and startups; comparable in being a Korean-domestic fund manager with institutional backing, though focused on earlier-stage deals than Synergy's growth-stage mandate.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment19 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Synergy IB Investment

Private Equity & Venture Capital Investment Managementsynergyib.co.kr

Synergy IB Investment firmographics

Firmographics
Name
Synergy IB Investment
Legal name
Synergy IB Investment Co., Ltd.
Website
https://synergyib.co.kr
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Synergy IB Investment industry classification

Industry
Product category
Private Equity & Venture Capital Investment Management
NAICS
Portfolio Management and Investment Advice (523940), Other Investment Pools and Funds (5259)
SIC
Investment Advice (6282)
akta.pro primary industry
Investment Management Advisory (RIA) (FSAEAAAB)

Keywords

  • Private investment management
  • Venture capital funding
  • Growth capital investing
  • Fund management services
  • Capital markets advisory

Where Synergy IB Investment is headquartered

Location

Headquarters

HQ city
Yongsan
HQ country
South Korea
HQ region
Asia

Offices1 record

Markets served

Synergy IB Investment business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D, Others

Revenue model

  1. Fund Management Fees and Carried Interest: Synergy IB Investment generates revenue through managing investment funds, including management fees and performance-based carried interest from successful portfolio company exits. The firm has demonstrated strong exit performance with 107 fully exited investments.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Synergy IB Investment product offering

Product offering

Core offering

Synergy IB Investment is a Korean private investment firm that raises and manages multiple investment funds backed by top-tier domestic financial institutions, providing continuous capital supply and strategic value creation to growth-stage companies from startup through IPO and beyond. The firm deploys capital via direct equity investments, charging management fees and carried interest, and has accumulated KRW 1.1 trillion in AUM across 558 deals, 162 funds raised, and 107 fully exited investments with a 23.2% average gross IRR.

Product overview

Synergy IB Investment operates as a single, unified investment management platform offering full-lifecycle capital support to companies from startup through IPO and beyond. The firm manages investment funds across multiple stages and sectors, providing strategic capital allocation, deal structuring, and portfolio management services to its limited partners and portfolio companies. Founded in 2014, the firm has raised 162 funds with KRW 1.1 trillion in AUM across 558 deals, delivering a 23.2% average gross IRR through disciplined, cycle-resilient investing. The firm does not appear to offer distinct named investment products or sub-brands based on available information.

Differentiator

Problem solved

Functional benefit

Products and services

  • Investment Fund Management Management of multiple investment funds backed by top-tier Korean financial institutions, with 162 funds raised and KRW 1.1 trillion in accumulated AUM across 558 deals. The service targets Korean growth-stage companies and institutional limited partners, delivering a 23.2% average gross IRR through cycle-resilient investing with a 2.5-year average holding period.
  • Full-Cycle Equity Capital Deployment Direct equity investment in Korean growth-stage companies across every stage of the corporate lifecycle, from startup through IPO and post-IPO expansion. Supported 200+ portfolio companies as evidenced, providing continuous capital supply and strategic value creation alongside funding.

Quantifiable outcome

  • 23.2% average gross IRR achieved across portfolio
  • +2 more outcomes

Companies that use Synergy IB Investment

Customer profile

Segments2 records

Ideal customer profiles2 records

Synergy IB Investment technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Synergy IB Investment partnerships and signals

Strategic signal

Scale indicators7 records

Recent moves2 records

Expansion highlights4 records

Synergy IB Investment competitors and assessment

Company assessment

Direct peers

  • KB Investment: PE/VC arm of KB Financial Group, one of Korea's largest financial groups, managing multiple funds with institutional LPs across growth stages — directly comparable in scale, LP base, and Korean capital markets focus.
  • STIC Investments: Korean PE/VC firm raising and managing multiple growth and venture funds backed by Korean financial institutions; directly comparable in fund vintage model and growth-stage deal sourcing.
  • IMM Investment: Korean private equity firm managing growth and buyout funds with institutional LP backing; comparable to Synergy in fund structure, Korean institutional capital base, and full-lifecycle investment approach.
  • TS Investment: Korean private investment firm managing multiple funds focused on growth-stage companies with institutional LP backing; similar in structure, target segment, and domestic Korean market focus to Synergy IB.
  • Korea Investment Partners: One of Korea's largest and most established venture capital and growth equity firms, managing multi-stage funds with top-tier Korean institutional LPs — a direct comparator to Synergy IB's growth-stage investment model.
  • Mirae Asset Capital: Investment arm of the Mirae Asset Financial Group, managing PE/VC funds and direct investments in Korean growth companies; comparable in institutional LP base and capital markets discipline.
  • SV Investment: Korean venture and growth capital firm managing multiple funds backed by Korean financial institutions, with a similar full-lifecycle investment thesis.
  • HB Investment: Korean private investment firm managing growth-stage funds with institutional LP backing, similar fund vintage structure and disciplined investment approach.
  • Korea Investment Accelerator: Korean early-stage investor that co-led the PhyxUp Health seed round with Synergy IB; operates a comparable fund-driven model investing in growth-stage and cross-border Korean-led deals.

Regional players

  • BonAngels Venture Partners: Early-stage Korean VC focused on Korean founders and startups; comparable in being a Korean-domestic fund manager with institutional backing, though focused on earlier-stage deals than Synergy's growth-stage mandate.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Synergy IB Investment social profiles

Digital presence

Synergy IB Investment financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Synergy IB Investment leadership team

Management profile

Number of profiles

Profiles3 records

Synergy IB Investment funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Synergy IB Investment M&A and investment

M&A and investment

M&A

Investments19 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Synergy IB Investment

What does Synergy IB Investment do?

Synergy IB Investment is a Korean private investment firm that raises and manages multiple investment funds backed by top-tier domestic financial institutions, providing continuous capital supply and strategic value creation to growth-stage companies from startup through IPO and beyond. The firm deploys capital via direct equity investments, charging management fees and carried interest, and has accumulated KRW 1.1 trillion in AUM across 558 deals, 162 funds raised, and 107 fully exited investments with a 23.2% average gross IRR.

Is Synergy IB Investment a public or private company?

Synergy IB Investment is a private company. It is classified as unknown and is currently operating.

When was Synergy IB Investment founded?

Synergy IB Investment was founded in 2014. It employs 11 to 50 people.

Where is Synergy IB Investment based?

Synergy IB Investment is headquartered in Yongsan, South Korea, in the Asia region.

How does Synergy IB Investment make money?

One revenue line is on record: fund Management Fees and Carried Interest.

Who are Synergy IB Investment's main competitors?

Direct peers on record are KB Investment, STIC Investments, IMM Investment, TS Investment, Korea Investment Partners, Mirae Asset Capital, SV Investment, HB Investment and Korea Investment Accelerator. BonAngels Venture Partners is listed as a regional player.

Does Synergy IB Investment have an API?

No public API is recorded for Synergy IB Investment.

What industry is Synergy IB Investment in?

Synergy IB Investment's product category is Private Equity & Venture Capital Investment Management. Its primary akta.pro industry code is FSAEAAAB, Investment Management Advisory (RIA). Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Nate[Pinpoint] [Comeron] Synergy IB Investment and Repeated Transactions, Is the Reality Defense of Management Rights? : Nate NewsComeron, a Korean precision parts manufacturer, has repeatedly invested funds in Synergy IB Investment's investment funds totaling 34.7 billion won over three years, with the book value of invested funds reaching 15.5 billion won as of the end of Q1. Market observers suspect these transactions may constitute quid pro quo deals to defend management rights, as Synergy IB Investment had previously launched activist campaigns proposing higher dividends and stock buybacks before suddenly ceasing shareholder activities and selling its shares in 2020. Comeron maintains that the investments were made to utilize surplus funds in profitable vehicles.VenturesquareFixUp Health, seed investment attractionFixUp Health Inc., an AI-based remote therapeutic monitoring (RTM) startup, secured seed funding from Korea Investment Accelerator and Synergy IB Investment on the 17th, following a prior pre-seed round, to expand its share in the US rehabilitation healthcare market. The company, US-headquartered and founded by a clinical director with a Harvard School of Public Health background, uses AI analytics and automation to improve patient care continuity and support clinical decision-making. The investment will fund service expansion across major US cities, with the company already deployed in hospitals and clinics nationwide, including Harvard Medical School-affiliated institutions.DigitaltodayFixup Health, attracting seed investment... knocking on the door of the US rehabilitation medical market with AI-based remote solutions.AI-based Remote Therapeutic Monitoring startup Fixup Health announced it has secured seed investment from Korea Investment Accelerator, Synergy IB Investment, DHP, and Rabbit VC, building on prior pre-seed funding. The company, founded by Harvard public health graduate and rehabilitation specialist CEO Lim Sang-won and headquartered in the U.S., plans to use the funding to expand its AI-based RTM technology and services across major U.S. metropolitan areas in the rehabilitation medical market.스타트업엔(StartupN)Korean-American Fixup Health secures seed investment... targeting the U.S. healthcare market head-on with AI remote rehabilitation.FixUp Health, a Korean-American digital healthcare startup based in Boston, has completed a seed round investment led by Korea Investment Accelerator and Synergy IB Investment to advance its AI-based Remote Therapeutic Monitoring solution for the U.S. rehabilitation market. The company's RTM technology addresses structural inefficiencies in U.S. rehabilitation healthcare, including low patient compliance and administrative burden on healthcare professionals, and has been adopted by various healthcare settings including institutions under Harvard Medical School. The company plans to use the funding to expand its service areas across major U.S. cities, focusing on aggressive sales network expansion.PlatumAI drug development startup 'Aestec' secures pre-A investment.Aestec, an AI drug development startup, completed a pre-A round of investment with undisclosed amount. Synergy IB Investment and Ascend Ventures participated as financial investors, and a domestic pharmaceutical company joined as a strategic investor. The funds will support IND preparation for EST-101 and research into anticancer and degenerative brain disease agents.MtSocar's Park Jae-wook is also a favorite... 'E-commerce indicator analysis' Sigro, attracting seed investment.Sigro, an e-commerce performance data integration solution, announced on the 16th that it has secured undisclosed seed investment from institutional investors including Spring Camp, Schmidt, Tap Angel Partners and Synergy IB, plus individual investors such as Socar's Park Jae-wook, Sendbird's Kim Dong-sin and Qualson's Park Soo-young. The company plans to use the funds to strengthen its data capabilities, advance technology and hire specialized talent.